VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,691 | -55.7% | 1,354,400 | +15.9% | 0.02% | -46.3% |
| Q2 2023 | $28,653 | +6.1% | 1,168,100 | +0.7% | 0.04% | +13.9% |
| Q1 2023 | $27,005 | +0.8% | 1,160,500 | +9.6% | 0.04% | -2.7% |
| Q4 2022 | $26,788 | -99.9% | 1,058,400 | -30.0% | 0.04% | -9.8% |
| Q3 2022 | $29,161,000 | +103.6% | 1,512,494 | +168.9% | 0.04% | +141.2% |
| Q2 2022 | $14,324,000 | +490.0% | 562,400 | +495.8% | 0.02% | +466.7% |
| Q1 2022 | $2,428,000 | +0.2% | 94,400 | +63.0% | 0.00% | 0.0% |
| Q4 2021 | $2,424,000 | -36.0% | 57,900 | -27.7% | 0.00% | -40.0% |
| Q2 2021 | $3,787,000 | +88.9% | 80,102 | +36.9% | 0.01% | +150.0% |
| Q1 2020 | $2,005,000 | – | 58,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |